Making a Nobel-winning chemistry reaction even better
New catalyst offers greater control over the synthesis of organic cyclic compounds, including potential cancer drugs.
New catalyst offers greater control over the synthesis of organic cyclic compounds, including potential cancer drugs.
Announces lease of space in building being developed by MIT
Bristol‐Myers Squibb, Johnson & Johnson, Life Technologies, Pfizer and Quintiles will support initiatives in regulatory science and oncology innovation.
MIT chemists engineer the periwinkle plant to produce compounds that could become more effective cancer drugs.
Microchip technology rapidly identifies compounds for regrowing nerves, in live animals.
MIT chemical engineers demonstrate a new way to dramatically boost bacteria’s manufacturing abilities.
MIT chemists have synthesized a family of natural compounds that have shown promise in killing tumor cells.
Researchers’ solution to longstanding mystery could enable better inkjet printing and drug-dispensing systems.
Organizations will collaborate in multiple areas of oncology research and technology development.
MIT chemists’ answer to long-standing problem could have a big impact on pharmaceutical business.
MIT biologists show how tumors can become resistant to the commonly used chemotherapy drug cisplatin.
Will be used to examine globalization and regulatory compliance